Guangdong Taiantang Pharmaceutical Co., Ltd. (002433.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap1.91B
Enterprise Value3.04B
P/E Ratio-0.09
PEG Ratio0
Price/Sales Ratio0.5
Price/Book Ratio0.48
Enterprise/Revenue3.26
Enterprise/EBITDA-4.27

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterMarch 31, 2024

Profitability

Profit Margin-5.39
Operating Margin-5.39
AD

Management Effectiveness

Return On Assets-0.66
Return On Equity-1.09

Income Statement

Revenue410.36M
Revenue/Share0.53
Gross Profit69.17M
EBITDA-312.93M
Net Income-2.21B
Diluted EPS-2.88

Balance Sheet

Total Cash93.59M
Total Cash/Share0.16
Total Debt1.25B
Total Debt/Equity2.88
Current Ratio0.51
Book Value Per Share0.52

Price History

52-Week Change-87.14
52-Week High3.35
52-Week Low0.19
Moving Average 50 Days0.44
Moving Average 200 Days1.84

Statistics

Average Volume14.66M
Shares Outstanding766.77M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.03
Last Split Factor2:1
Last Split DateApril 22, 2014
AD